FDA User Fee Renewal Should Include Pre-Market Improvements - Industry
This article was originally published in The Gray Sheet
Executive Summary
Consumer advocates are suggesting FDA request considerably more funding from device companies in the next round of user fee negotiations, but companies are reluctant to foot more of the bill for device reviews without seeing promised improvements in FDA's pre-market program
You may also be interested in...
AdvaMed Urges A Different Approach To User Fee Performance Goals
AdvaMed says it wants FDA to set new user fee performance goals that better reflect the total time it takes to get a product through FDA and onto the market.
AdvaMed Urges A Different Approach To User Fee Performance Goals
AdvaMed says it wants FDA to set new user fee performance goals that better reflect the total time it takes to get a product through FDA and onto the market.
MDMA Presses For More Urgency In Changing FDA Mindset
Member companies of the Medical Device Manufacturers Association recently hashed out issues they wanted prioritized for 2011. They came up with five general themes, but one clearly dominated: making FDA medical device reviews more predictable.